These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1553101)

  • 1. Behavioural pharmacology of 5-HT3 receptor ligands.
    Barnes JM; Barnes NM; Cooper SJ
    Neurosci Biobehav Rev; 1992; 16(1):107-13. PubMed ID: 1553101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychopharmacology of 5-HT3 receptors.
    Costall B; Naylor RJ; Tyers MB
    Pharmacol Ther; 1990; 47(2):181-202. PubMed ID: 2203069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system.
    Kilpatrick GJ; Hagan RM; Gale JD
    Behav Brain Res; 1996; 73(1-2):11-3. PubMed ID: 8788470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astra Award Lecture. The psychopharmacology of 5-HT3 receptors.
    Costall B; Naylor RJ
    Pharmacol Toxicol; 1992 Dec; 71(6):401-15. PubMed ID: 1362267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse.
    Hagan RM; Kilpatrick GJ; Tyers MB
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S68-75. PubMed ID: 7831443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic potential of 5-HT3 receptor antagonists.
    Costall B; Naylor RJ
    Pharmacol Toxicol; 1992 Mar; 70(3):157-62. PubMed ID: 1349746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies.
    Mylecharane EJ
    Behav Brain Res; 1996; 73(1-2):1-5. PubMed ID: 8788468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties and functions of central 5-HT3 receptors.
    Costall B; Naylor RJ
    Therapie; 1991; 46(6):437-44. PubMed ID: 1840228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 5-HT3 receptors in drug dependence.
    Grant KA
    Drug Alcohol Depend; 1995 May; 38(2):155-71. PubMed ID: 7671767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.
    Engleman EA; Rodd ZA; Bell RL; Murphy JM
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):454-67. PubMed ID: 19128203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the A10 dopamine system: electrophysiological studies of the role of 5-HT3-like receptors.
    Wang RY; Ashby CR; Zhang JY
    Behav Brain Res; 1996; 73(1-2):7-10. PubMed ID: 8788469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT3 receptors and central effects of ethanol.
    Kostowski W
    Pol J Pharmacol; 1996; 48(3):243-54. PubMed ID: 9112659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Eur J Pharmacol; 1997 May; 325(2-3):129-35. PubMed ID: 9163559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
    Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ
    Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic.
    Lovinger DM
    Neurochem Int; 1999 Aug; 35(2):125-30. PubMed ID: 10405996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat.
    Kankaanpää A; Meririnne E; Seppälä T
    Psychopharmacology (Berl); 2002 Feb; 159(4):341-50. PubMed ID: 11823886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.
    Tyers MB
    Therapie; 1991; 46(6):431-5. PubMed ID: 1840227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic mechanisms in anxiety.
    Eison AS; Eison MS
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):47-62. PubMed ID: 8115673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.
    Ago Y; Nakamura S; Baba A; Matsuda T
    J Pharmacol Sci; 2008 Jan; 106(1):15-21. PubMed ID: 18198473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.